- Home
- SNDX vs ICHR Comparison
SNDX vs ICHR Comparison
Compare SNDX & ICHR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNDX
- ICHR
- Stock Information
- Founded
- SNDX 2005
- ICHR 1999
- Country
- SNDX United States
- ICHR United States
- Employees
- SNDX N/A
- ICHR N/A
- Industry
- SNDX Biotechnology: Pharmaceutical Preparations
- ICHR Semiconductors
- Sector
- SNDX Health Care
- ICHR Technology
- Exchange
- SNDX Nasdaq
- ICHR Nasdaq
- Market Cap
- SNDX 1.1B
- ICHR 1.0B
- IPO Year
- SNDX 2016
- ICHR 2016
- Fundamental
- Price
- SNDX $13.08
- ICHR $30.84
- Analyst Decision
- SNDX Strong Buy
- ICHR Strong Buy
- Analyst Count
- SNDX 10
- ICHR 8
- Target Price
- SNDX $36.20
- ICHR $42.50
- AVG Volume (30 Days)
- SNDX 2.6M
- ICHR 225.6K
- Earning Date
- SNDX 02-25-2025
- ICHR 02-04-2025
- Dividend Yield
- SNDX N/A
- ICHR N/A
- EPS Growth
- SNDX N/A
- ICHR N/A
- EPS
- SNDX N/A
- ICHR N/A
- Revenue
- SNDX $16,000,000.00
- ICHR $819,230,000.00
- Revenue This Year
- SNDX N/A
- ICHR $5.99
- Revenue Next Year
- SNDX $14.15
- ICHR $15.26
- P/E Ratio
- SNDX N/A
- ICHR N/A
- Revenue Growth
- SNDX N/A
- ICHR N/A
- 52 Week Low
- SNDX $12.06
- ICHR $26.40
- 52 Week High
- SNDX $25.34
- ICHR $46.43
- Technical
- Relative Strength Index (RSI)
- SNDX 41.29
- ICHR 45.10
- Support Level
- SNDX $12.40
- ICHR $29.64
- Resistance Level
- SNDX $13.16
- ICHR $33.23
- Average True Range (ATR)
- SNDX 0.65
- ICHR 1.32
- MACD
- SNDX 0.10
- ICHR -0.13
- Stochastic Oscillator
- SNDX 39.38
- ICHR 24.57
About SNDX Syndax Pharmaceuticals Inc.
Syndax Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing a pipeline of combination therapies in multiple cancer indications. The company's product candidates are entinostat which has direct effects on both cancer cells and immune regulatory cells, SNDX-6352 and SNDX-6352, an anti-CSF-1R monoclonal antibody, to enhance the body's immune response on tumors that have shown sensitivity to immunotherapy. Business activity of the group is primarily functioned through the region of United States.
About ICHR Ichor Holdings
Ichor Holdings Ltd is engaged in the design, engineering, and manufacturing of critical fluid delivery subsystems and components for semiconductor capital equipment. The product offerings include gas and chemical delivery subsystems, collectively known as fluid delivery subsystems, which are key elements of the process tools used in the manufacturing of semiconductor devices. The company also manufactures machined components, weldments, and proprietary products for use in fluid delivery systems. Geographically, the company operates in the United States, the United Kingdom, Singapore, Malaysia, Korea, and Mexico, of which a majority of the revenue is generated from Singapore.